Literature DB >> 22674098

Neonatal sepsis: A, B, C--don't ever forget herpes.

Lucy Anne Fitzgerald1, Diluki Kevitiyagala, Steve Gould, Stanley Zengeya.   

Abstract

A 5-day-old male presents to the emergency department septic and jaundiced, is resuscitated and started on broad spectrum intravenous antibiotics. However tragically in this case despite showing initial signs of stabilisation, he deteriorated with refractory metabolic acidosis and disseminated intravascular coagulation, and later passed away. At postmortem, disseminated herpes simplex virus-1 (HSV-1) was found. Paediatricians are well aware of the risk factors for bacterial neonatal sepsis and actively seek information from parents to identify those children at risk. When however should a viral aetiology be considered? Should all neonates receive empirical therapy until proven otherwise? The authors review the literature surrounding neonatal HSV infection and discuss the potential pitfalls of empirical treatment.

Entities:  

Mesh:

Year:  2011        PMID: 22674098      PMCID: PMC3214215          DOI: 10.1136/bcr.07.2011.4423

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Improving the care of patients with genital herpes.

Authors:  S Drake; S Taylor; D Brown; D Pillay
Journal:  BMJ       Date:  2000-09-09

2.  Could neonatal disseminated herpes simplex virus infections be treated earlier?

Authors:  Katy J Fidler; Christine M Pierce; W David Cubitt; Vas Novelli; Mark J Peters
Journal:  J Infect       Date:  2004-08       Impact factor: 6.072

3.  In defense of empiric acyclovir therapy in certain neonates.

Authors:  Sarah S Long
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

4.  When should you initiate acyclovir therapy in a neonate?

Authors:  David W Kimberlin
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

5.  Natural history of neonatal herpes simplex virus infections in the acyclovir era.

Authors:  D W Kimberlin; C Y Lin; R F Jacobs; D A Powell; L M Frenkel; W C Gruber; M Rathore; J S Bradley; P S Diaz; M Kumar; A M Arvin; K Gutierrez; M Shelton; L B Weiner; J W Sleasman; T M de Sierra; S J Soong; J Kiell; F D Lakeman; R J Whitley
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

6.  Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

Authors:  D W Kimberlin; C Y Lin; R F Jacobs; D A Powell; L Corey; W C Gruber; M Rathore; J S Bradley; P S Diaz; M Kumar; A M Arvin; K Gutierrez; M Shelton; L B Weiner; J W Sleasman; T M de Sierra; S Weller; S J Soong; J Kiell; F D Lakeman; R J Whitley
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

7.  Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study.

Authors:  Rhonda Y Kropp; Thomas Wong; Louise Cormier; Allison Ringrose; Sandra Burton; Joanne E Embree; Marc Steben
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

8.  Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.

Authors:  Z A Brown; J Benedetti; R Ashley; S Burchett; S Selke; S Berry; L A Vontver; L Corey
Journal:  N Engl J Med       Date:  1991-05-02       Impact factor: 91.245

9.  The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates.

Authors:  A Chantal Caviness; Gail J Demmler; Yvette Almendarez; B J Selwyn
Journal:  J Pediatr       Date:  2008-04-03       Impact factor: 4.406

10.  Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study.

Authors:  A Chantal Caviness; Gail J Demmler; Beatrice J Selwyn
Journal:  Pediatr Infect Dis J       Date:  2008-05       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.